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Objective: To assess the association of emphysema and airway disease assessed by volumetric
computed tomography (CT) with exercise capacity in subjects with chronic obstructive pulmo-
nary disease (COPD).
Methods: We studied 93 subjects with COPD (Forced Expiratory Volume in 1 s [FEV1] %pre-
dicted mean  SD 57.1  24.3%, female gender Z 40) enrolled in the Lung Tissue Research
Consortium. Emphysema was defined as percentage of low attenuation areas less than
a threshold of 950 Hounsfield units (%LAA-950) on CT scan. The wall area percentage
(WA%) of the 3rd to 6th generations of the apical bronchus of right upper lobe (RB1) were
analyzed. The 6-min walk distance (6MWD) test was used as a measure of exercise capacity.
Results: The 6MWD was inversely associated with %LAA-950 (r Z 0.53, p < 0.0001) and with
the WA% of 6th generation of RB1 only (r Z 0.28, p Z 0.009). In a multivariate regression
model including CT indices of emphysema and airway disease that were adjusted for demo-
graphic and physiologic variables as well as brand of CT scanner, only the %LAA-950 remained
significantly associated with exercise performance. Holding other covariates fixed, this modelry and Critical Care Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, 75
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1146 A.A. Diaz et al.showed that a 10% increase of CT emphysema reduced the distance walked in 6 min 28.6 m
(95% Confidence Interval Z 51.2, 6.0, p Z 0.01).
Conclusion: These results suggest that the extent of emphysema but not airway disease
measured by volumetric CT contributes independently to exercise limitation in subjects with
COPD.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
A reduction in exercise capacity is frequent in subjects with
chronic obstructive pulmonary disease (COPD)1 and is tradi-
tionally associated with impaired lung function.2e6 There is,
however, increasing recognition that spirometric measures
of lung function alone do not explain all the variance found
in clinical measures of disease. As detailed by Reilly in his
editorial to the UPLIFT study, COPD appears to be an
aggregate of several unique subtypes.7 Given this hetero-
geneous population, new measures of disease such as
computed tomography (CT) assessment of emphysema and
airway disease are of great interest in helping to understand
disease pathophysiology and standard clinical measures such
as exercise capacity.
The 6-min walk distance test (6MWD) is a commonly used
measureofexercise capacity in subjectswithCOPD. It requires
minimal equipment to perform and is widely available.8 While
CT is increasingly used to quantitatively assess both the
emphysema and airway disease in COPD,9e18 studies of
their contribution to exercise capacity are more limited.19e21
Gould et al20 and Lee et al21 reported an association
between emphysema assessed by CT and exercise capacity
assessed bywalking tests, but the relation of airway disease to
exercise capacity, however, has not been demonstrated.
Based on prior studies revealing the inverse correlation
between CT airway disease and lung function,12,14 we
hypothesize that CT measures of airway disease would
provide complimentary information to CT measures of
emphysema in predicting exercise capacity measured by
6MWD independent of lung function. We undertook this study
using data from Lung Tissue Research Consortium (LTRC),
a National Heart, Lung and Blood Institute initiative to char-
acterize subjects with chronic pulmonary diseases such as
COPD.Methods
Subjects selection
The data used in this study were collected as part of the
LTRC and included measures of lung function, exercise
testing, and volumetric CT scanning of the chest performed
prior to lung volume reduction surgery, transplantation,
and resection for suspected malignancy (www.ltrcpublic.
com). Subjects were evaluated for inclusion in our study
if they had a diagnosis of COPD (postbronchodilator forced
expiratory volume in 1 s to forced expiratory vital capacity
ratio [FEV1/FVC] <0.7) and a high resolution volumetric CT
scan available for quantitative analysis. Five out of the 99
patients that met the two above criteria were eliminatedbecause of a history of chronic heart failure which has been
demonstrated to influence exercise performance.22 A sixth
subject was excluded because of a giant bulla in the right
lung which resulted in mediastinal displacement. The final
study cohort consisted of 93 subjects and informed consent
was obtained from each participant. The study was
approved by the Institutional Review Board of Brigham and
Women’s Hospital (BWH).
Physiologic assessment
All subjects underwent standardized spirometric measures of
lung function according to American Thoracic Society (ATS)
guidelines.23 The postbronchodilator FEV1 and FVC were
recorded in liters and expressed as percentages of predictive
values (FEV1%P and FVC%P) using standardized prediction
equations.24 Lung volume measurements were performed by
body plethysmography. The residual volume, total lung
capacity, and the residual volume to total lung capacity ratio
were expressed as percentages of predicted values (RV%P,
TLC%P and RV/TLC%P, respectively).25 The 6MWD was per-
formed in a standardized manner following ATS recommen-
dations.26 This test was typically performed once prior to
a subject undergoing surgery. In four patients more than one
walk test was takenwhile theywere awaiting transplantation.
In these cases, thewalk test in closest proximity to the surgery
was evaluated. Oxygen saturation (SO2) was measured before
and at the end of the walk test. Oxygen supplementation was
titrated to achieve a resting SO2 level of at least 88% prior to
starting the test. The walking distance was recorded in
meters.Imaging assessment
The radiology core laboratory defined CT protocols for
LTRC.27 CT scanners follow the American College of Radi-
ology guidelines for accreditation (www.acr.org/
accreditation/computed). Computed tomographic images
were acquired in the supine position at full inflation using
both General Electric (GE) and Siemens scanners. GE
Protocol: 55 subjects underwent CT scanning using a GE CT
scanner. Images were acquired using a 30 cm field of view
(FOV) in a GE LightSpeed 16 multislice scanner using a tube
voltage of 140 kVp, a tube current of 300 or 375 mA for most
subjects (n Z 48) and variable doses for the remaining
subjects. Images were reconstructed using the bone algo-
rithm at 1.25 mm slice thickness and 0.625 mm interval.
Siemens Protocol: 38 subjects underwent CT scanning by
using Siemens Sensation 10 or 64 multislice scanners. Images
were similarly acquired using a 30 cm FOV at 140 kVp with an
automated dose modulation. Images were reconstructed
Table 1 Anthropometric, lung function, exercise capacity,
CT assessment, and procedure data for the 93 subjects.
Variableb Mean  (SD)a
Age (years) 66.7  8.8
Female Gender (n, %) 40 (43)
Body Mass Index (kg/m2) 26.2  4.7
Smoking History (pack years) 54.2  31.7
FEV1 (%predicted) 57.1  24.3
FVC (%predicted) 81.6  19.3
FEV1/FVC ratio 0.5  0.2
RV (%predicted) 159.4  57.9
TLC (%predicted) 111.9  18.9
RV/TLC ratio (%predicted) 131.6  32.3
PaO2 (mm Hg) 80.3  31.8
PaCO2 (mm Hg) 39.9  6.5
Six-Minute Walk Distance (m) 331.2  149.4
SpO2 at the end of 6MWD (%) 91.7  6.5
%LAA-950 (%) 16.8 (9.0e32.6)
WA% of 3rd generation of RB1 (%) 60.5  6.2
WA% of 4th generation of RB1 (%) 66.4  7.7
WA% of 5th generation of RB1 (%) 72.3  7.5
WA% of 6th generation of RB1 (%) 78.8  6.5
Type of procedure (n, %)
Wedge resection or Lobectomy 57 (61)
Lung Volume Reduction Surgery 11 (12)
Lung Transplant 10 (11)
Surgical Lung Biopsy 5 (5)
No Tissue Obtained 10 (11)
a Values are expressed as mean  standard deviation, except
for female gender and type of procedure n (%), and %LAA-950
median (interquantile range).
b Missing values: smoking history 4 subjects; residual volume
and total lung capacity 4 subjects; wall area percent of 3rd to
6th generation airways 5, 4, 4, and 6 subjects, respectively.
PaO2, Partial Pressure of Oxygen in Arterial Blood; PaCO2,
Partial Pressure of Carbon Dioxide in Arterial Blood; SpO2,
Oxygen Saturation Measured by Pulse Oximetry at the imme-
diate termination of the 6MWD; %LAA-950, Percentage of Low
Attenuation Areas Below 950 Hounsfield Units; WA%, Wall Area
Percentage; RB1, Apical Bronchus of the Right Upper Lobe.
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Emphysema and airway analysis
Quantitative measures of emphysema for the whole lung
and for airway disease were calculated using open-source
software (www.airwayinspector.org). Emphysema was
defined as low attenuation areas using a Hounsfield Unit
(HU) threshold of 950 (%LAA-950).10 Single-slice airway
measurements were collected in the apical bronchus of the
right upper lobe (RB1). RB1 was chosen because its long axis
is generally perpendicular to axial imaging plane and prior
studies have shown measures taken at this site correlate
with lung function and predict small airway dimensions
assessed by histological means.12,13 Analysis was performed
in the 3rd (segmental bronchus), 4th, 5th, and 6th gener-
ation. In each generation, one measurement was taken at
what was judged to be the central portion of the segment
of interest in an image reformatted orthogonally to the long
axis of the lumen airway. The Phase Congruency
method28,29 for airway segmentation was used to define the
lumen-wall and wall-parenchymal boundaries and total
airway area (Ao), airway lumen (Ai), and wall area
percentage (WA%) defined as (AoeAi)/Ao  100% were
measured at each point of interest.30
Statistical analysis
Baseline characteristics are expressed as mean and SD or
median and interquantile range when appropriate. Pearson’s
correlation coefficients were used to assess univariate rela-
tionships between CT-based measures of airway disease and
emphysema, lung function, and 6MWD. Multivariate linear
regression models were created using 6MWD as the response
variable and %LAA-950 and WA% of 6th generation of RB1
together as explanatory variables. WA% of 6th generation was
chosen because it correlated significantly with 6MWD in
univariate analysis. Adjustment was done for the following
known factors that influence a subject’s exercise capacity:
age, gender, body mass index (BMI),31,32 and RV/TLC%P. RV/
TLC ratio is an estimate of hyperinflation that has been shown
that influences subject’s exercise performance.3 Model
adjustmentwas also done for scanner brand and cancer status
(presence or absence of malignancy on surgical pathology).
The analysis was performed with SAS version 9.1 (Cary, NC).
A P value of 0.05 was considered statistically significant.
Results
Table 1 shows baseline characteristics of the study
subjects. The mean FEV1 was 1.6  0.7 L (range: 0.5e
3.3 L). Fifteen out of 93 (16%) subjects used supplemental
oxygen for the walk test. These 15 subjects had significant
lower FEV1%P (mean  SD 37.1  24.7% vs 60.1  22.2%),
higher RV/TLC%P (209.2  80.7% vs 151.1  49.1%), shorter
distance walked (193.2  106.1 m vs 357.7  142.1 m), and
higher %LAA-950 (median 42.2 [interquantile range 25e
51%]) than the 78 non-oxygen users. Fifty-eight of the 93
subjects received a diagnosis of cancer. Data by cancer
status is shown in Table 2.Association between CT emphysema, WA%, lung
function, and exercise capacity
CT indices of both emphysema and airway disease were
inversely associated with exercise capacity. Subjects with
higher CTemphysema (rZ0.53, p< 0.0001, Fig. 1) or WA%
of the 6th generation of RB1 (r Z 0.28, pZ 0.009, Fig. 2)
walked significantly less in 6 min. There was not a significant
correlation between 6-MWD and WA% of the 3rd to the 5th
generation airways (Table 3). Subjects with higher CT
emphysemahad lower BMI (rZ0.25,pZ 0.015) andFEV1%P
(rZ 0.68, p < 0.0001), and higher degree of hyperinflation
estimated by RV/TLC%P (rZ 0.56, p< 0.0001). Subjects with
greaterWA%of the 4th (rZ0.23,pZ 0.03), 5th (rZ0.22,
pZ 0.04), and 6th generation (rZ0.39, pZ 0.0002) of RB1
also had lower FEV1%P.
CT emphysema but not airway disease remained signifi-
cantly associated with exercise capacity in the multivariate
analysis adjusted for age, gender, BMI, RV/TLC%P, scanner
Table 2 Anthropometric, lung function, exercise capacity, and CT assessment data for the 93 subjects by cancer status.
Variable Subjects with cancer (n Z 58) Subjects without cancer (n Z 35)
Mean  SDa
Age (years) 69.8  6.8 61.5  9.4**
Female Gender (n, %) 26 (44.8) 14 (40.0)
Body Mass Index (kg/m2) 26.0  4.6 26.5  4.9
Smoking History (pack years) 55.5  34.6 52.1  26.5
FEV1 (% predicted) 68.5  18.2 36.3  18.6**
FVC (% predicted) 88.4  16.4 70.3  18.6**
FEV1/FVC ratio 0.6  0.1 0.4  0.2**
RV (%predicted) 137.0  37.7 195.3  67.9**
TLC (%predicted) 107.9  15.9 118.5  21.6**
RV/TLC ratio (%predicted) 119.4  23.2 152.0  35.2**
Six-Minute Walk Distance (m) 402.7  102.5 212.6  139.8**
%LAA-950% 12.9 (8.0e19.2) 34.8 (25e44.5)**
WA% of 3rd generation of RB1 (%) 61.1  6.0 59.7  6.6
WA% of 4th generation of RB1 (%) 65.5  7.1 67.9  8.4
WA% of 5th generation of RB1 (%) 71.8  6.9 73.1  8.5
WA% of 6th generation of RB1 (%) 77.1  6.5 81.6  5.7**
**P value <0.05.
%LAA-950, Percentage of Low Attenuation Areas Below 950 Hounsfield Units; WA%, Wall Area Percentage; RB1, Apical Bronchus of the
Right Upper Lobe.
a Values are expressed as mean  standard deviation, except for female gender n (%) and %LAA-950 median (interquantile range).
1148 A.A. Diaz et al.brand, and cancer status (Table 4). Holding other covariates
fixed, the adjusted effect estimate of %LAA-950 on exercise
capacity shows that a 10% increase of emphysema on CT scan
decreases the 6-min walking distance 28.6 m (95% Confi-
dence Interval 51.2, 6.0, p Z 0.014). The unadjusted
model for predicting 6MWD containing LAA%-950 and WA%
explained more variability in the 6MWD (R2 Z 0.29) than
a single-variable model containing lung volume measures as
predictors (for RV/TLC%P, R2 Z 0.15; for RV%P, R2 Z 0.13;
and for TLC%P, R2 Z 0.05).Discussion
In this study we observed that in univariate analysis whole
lung emphysema percentage assessed by volumetric CT and
airway wall thickening of only the 6th generation airway of
right upper lobe apical segment correlated with the distance
walked in 6 min in subjects with COPD. Multivariate analysisr = -0.53
p <0.0001
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Figure 1 Scatter plot of 6-min walk distance to emphysema
assessed by CT defined as percentage of low attenuation areas
below 950 Hounsfield Units (%LAA-950) in subjects with COPD.showed that in this cohort emphysemabut not airwaydisease
contributed independently to exercise capacity as assessed
by 6MWD.
The %LAA-950 is inversely associated with 6MWD sug-
gesting that emphysema has a deleterious impact on
exercise capacity. Previous studies examining the rela-
tionship between objective and semi-objective measures of
emphysema and exercise capacity have yielded conflicting
results. An early study found that CT emphysema correlated
with 12-min walk distance20 and Lee et al21 found that
%LAA-950 obtained from volumetric CT scans is inversely
correlated with 6MWD (r Z 0.53). In contrast to these,
Taguchi et al33 found that using a subjective visual assess-
ment of emphysema in 32 subjects with COPD there was no
relationship between their measures of emphysema and
6MWD. Technique differences and their smaller sample size
may explain the disparity with our results. In another
recent study, Mair et al34 did not find a correlation between
%LAA-950 and 6MWD. A lower median (5.5%) and a narrower
interquantile range of CT emphysema percentage
(1.6e17.5%) of their subjects may partly explain the
disparity with the present result.
Airway wall thickening of the most distal airway assessed
in this study was inversely related to 6MWD in univariate
analysis. A previous cited study failed to find such a rela-
tion.21 One reason for this discrepancy is that in the Lee
study only segmental bronchi were assessed. Our finding
suggests that airway wall thickening of a more distal airway
assessed by CT scanning is associated with changes in
6MWD. A partial explanation for the relationship between
WA% and 6MWD is that the airway wall thickening in COPD
leads to an increased airflow resistance, which reduces
ventilatory capacity and contributes to an increased sense
of effort in breathing during exercise.22 In COPD, the small
airways (2 mm or less in diameter) are the site of major
r = -0.28
p= 0.0091
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Figure 2 Scatter plot of 6-min walk distance to wall area
percentage (WA%) of the 6th generation of the apical bronchus of
the right upper lobe (RB1) assessed by CT in subjects with COPD.
CT indices and exercise capacity in COPD 1149airflow resistance35 and it has been shown that WA% of the
3rd generation of RB1 measured by CT is a surrogate for the
dimensions of those small airways measured by histological
means.13 When the airway thickening was included with CT
emphysema in an adjusted multivariate model, however,
only emphysema remained associated with 6MWD. Thus,
our CT assessment of COPD suggests that emphysematous
destruction of the lung more than airway remodeling of the
disease may be responsible for the effect on the reduction
of 6MWD. There may be several reasons for this observed
association.
First, elastic recoil loss of emphysema with subsequent
airway collapse lead to airflow limitation and gas trapping
could in turn lead to a reduction of the subject’s exercise
performance.22 Severe emphysema is also associated with
changes in the configuration of the bony chest and dia-
phragm that lead to a mechanical disadvantage of the
respiratory system. Butler36 showed an inverse correlation
between the area of the whole diaphragm and percentage of
the whole lung occupied by emphysematous lesions. In
addition, Lando et al37 showed that a change in diaphragm
length is correlated with better exercise performance afterTable 3 Pearson’s correlation coefficients (r) between
6-min walk distance, lung function, emphysema and airway
disease assessed by CT for the 93 subjects.
Variable Six-minute walk
distance (m)
r Value P Value
FEV1 (%predicted) 0.48 <0.0001
FVC (%predicted) 0.32 0.002
FEV/FVC ratio 0.47 <0.0001
RV (%predicted) 0.40 <0.0001
TLC (%predicted) 0.22 0.04
RV/TLC ratio (%predicted) 0.39 0.0002
%LAA-950 (%) 0.53 <0.0001
WA% of 3rd generation of RB1 (%) 0.12 0.35
WA% of 4th generation of RB1 (%) 0.18 0.09
WA% of 5th generation of RB1 (%) 0.10 0.37
WA% of 6th generation of RB1 (%) 0.28 0.009
%LAA-950, Percentage of Low Attenuation Areas Below 950
Hounsfield Units; WA%, Wall Area Percentage; RB1, Apical
Bronchus of the Right Upper Lobe.lung volume reduction surgery in patients with severe
emphysema. Finally, Matsuoka et al. recently showed an
inverse association between the cross sectional area of small
pulmonary vessels and emphysema.38 It has been suggested
that loss of pulmonary vasculature may lead to an increase in
pulmonary vascular resistance and a decrease in pulmonary
vascular compliance even in patients with mild emphy-
sema.39 The changes can cause an increased load on the
right ventricle39 that may lead to decreased left heart
filling40 and compromised oxygen delivery to muscles. Thus,
these changes may also explain the decrease in exercise
capacity seen in our subjects.
This study shows that objective analysis of volumetric CT
scans may provide additional information to phenotype
COPD. It can not only define the presence and extent of
emphysema and airway thickening, but may also predict
exercise impairment in subjects with COPD. This comple-
mentary information may be of utility for further under-
standing the relationship of lung structure and the clinical
manifestations of disease.
There are several limitations of this study. While a wide
range of lung function and a detailed physiologic and imaging
assessment of the LTRC subjects are obvious strengths of this
cohort, there is a subject selection bias inherent to the pop-
ulation enrolled in the LTRC as they were undergoing evalu-
ation for surgical resection of potentially cancerous lesions
apparent on preoperative CT images. Subjects with COPD and
cancer had better lung function and exercise performance,
less emphysema, and thinner 6th generation airway on CT
scans than their counterpartswithout cancer. Furthermore, in
multivariate analysis, the presence of cancer was
a confounder in the association between CT measures of
COPDand6MWDbecause it remained as a significantpredictor
in the model and decreased significantly the effect estimate
associated with emphysema. Thus, our study cohort does not
likely represent the general population of smokerswithCOPD.
Despite of this, the expected direction of the association
between %LAA and 6MWD found in this study is supported by
previous studies.20,21
Second, the LTRC is a multicenter initiative employing
different brands and generations of CT scanners. Despite
efforts to standardize image acquisition and reconstruc-
tion, there were likely systematic differences in CT scans
introducing bias in our results. However, present results on
the correlations of %LAA-950 with FEV1%P and BMI and of
4th to 6th airway generations of RB1 with FEV1%P are
consistent with previous studies12,14,17,18,20,21,30,34,41 and
are supportive of our findings regarding the relation of CT
indexes to 6MWD.
Finally, we assumed that WA% of 3rd to 6th generations of
RB1 may represent the airway dimensions of the rest of the
lungs. This may not be appropriate as it has been shown that
there are variations in airway dimensions and in correlations
between WA% and FEV1%P in the right upper and right lower
lobes.14 Further studies are needed to assess whether or not
there is variability in correlations betweenWA% and exercise
capacity through the lungs.
In summary, the present study suggests that airway wall
thickening of a distal airway generation and emphysema
assessed by CT correlates with 6-min walk distance in
subjects with COPD, but only emphysema seems to
contribute independently to exercise capacity. As this was
Table 4 Multivariate linear regression models for the association between 6-min walk distance (m) and CT indices.
CT indices Unadjusted Adjusteda
Parameter Estimate
(95% Confidence Interval)
P Value Parameter Estimate
(95% Confidence Interval)
P Value
%LAA-950 (%) 4.76 (6.71, 2.81) <0.0001 2.86 (5.12, 0.60) 0.014
WA% of 6th generation
of RB1 (%)
2.49 (6.94, 1.94) 0.27 1.18 (5.39, 3.02) 0.57
%LAA-950, Percentage of Low Attenuation Areas Below 950 Hounsfield Units; WA%, Wall Area Percentage; RB1, Apical Bronchus of the
Right Upper Lobe.
a The model was adjusted for age, gender (femaleZ 1), BMI, RVTLC%P, scanner brand (GE scannerZ 1) and cancer status (presence of
cancerZ1). R2 values for unadjusted and adjusted models were 0.29 and 0.54, respectively.
1150 A.A. Diaz et al.a retrospective analysis and the population study may not
be representative of the normal COPD population, further
prospective studies involving large study cohort are needed
to assess the observed relationship between CT indexes and
exercise capacity.
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